IL6 and Alzheimer disease: Inacute AD patients receiving total arch replacement administered withdexmedetomidine during the perioperative period, the IL-6 values weresignificantly lower than in those without dexmedetomidine use 4, 8, and 24 hoursafter the operation (Figure 8B)[4].